These results suggest that up-regulation of FOXG1 enhances tumorigenicity and promotes EMT in HCC cells, which may hold promise for development of novel therapeutic treatments to prevent metastasis. This evidence concerns the gene FOXG1 and hepatocellular carcinoma.